Novel Biomarker COX-2 May Have a Prognostic Role in Nasopharyngeal Carcinoma

The biomarker may be a predictor of response to treatment and cancer progression in nasopharyngeal carcinoma.

from Latest articles from Cancer Therapy Advisor Head and Neck Cancer https://ift.tt/2npDxi3